ABSTRACT
Interaction of a high-intensity short laser pulse with near-critical plasmas allows us to achieve extremely high coupling efficiency and transfer laser energy to energetic ions. One-dimensional particle-in-cell simulations are considered to detail the processes involved in the energy transfer. A confrontation of the numerical results with the theory highlights a key role played by the process of stimulated Raman scattering in the relativistic regime. The interaction of a 1 ps laser pulse (Iâ¼6×10^{18}Wcm^{-2} with an undercritical (0.5n_{c}) homogeneous plasma leads to a very high plasma absorption reaching 68% of the laser pulse energy. This permits a homogeneous electron heating all along the plasma and an efficient ion acceleration at the plasma edges and in cavities.
ABSTRACT
The relationship between microalbuminuria and tissue-type plasminogen activator antigen (tPA-ag) and fibrinogen was evaluated in non-diabetic subjects. Subjects were participants of the D.E.S.I. R. (Data from an Epidemiological Study on the Insulin Resistance syndrome) Study. Analyses were carried out on 2248 women and 2402 men for fibrinogen and on 272 women and 284 men for tPA-ag. Microalbuminuria was defined as urinary albumin concentration greater than 20 mg/l. Men with microalbuminuria had a 6% higher fibrinogen concentration than those without (3.07 g/l (95% confidence interval: 2.99,3.15) vs. 2.89 g/l (2.87,2.91), adjusted for age and smoking). This relationship existed in hypertensive as well as non-hypertensive subjects. The association between microalbuminuria and tPA-ag existed only in hypertensive men, those with microalbuminuria having a 21% higher tPA-ag than those without (4.39 ng/ml (3.70,5.08) vs. 3.63 ng/ml (3.32,3.94), adjusted for age and smoking). Adjustment for other risk markers for cardiovascular disease did not change the results. There was no relationship between microalbuminuria and these haemostatic factors in women. The results of this study suggest that in non-diabetic men, microalbuminuria is associated with fibrinogen, but with tPA-ag only when concomitant with hypertension.
